3 years ago, I was in the Community of Leaders group and can say it had such a huge impact on how I lead - I recommend this to anyone who wants to be a more engaged and effective leader! Time well spent!
First human #H5N1 case of 2026 in #Cambodia: a 30-year-old man from Kampot province. Sequencing, virus isolation & animal investigations ongoing. Dead chicken at home before onset. Patient has since recovered. 🦠💉😷🐓🥼🔬🧪
Sequencing, contact tracing, and poultry investigations ongoing.
Not surprisingly, most adults healthcare-associated respiratory virus infections are immunocompromised and they account for the sickest patients. A key signal to better protect our most vulnerable patients.
onlinelibrary.wiley.com/doi/10.1111/...
But worth it for piece of mind.
It’s actually hard to get the vaccine - we got ours but it required pre-paying for the doses and having delays in getting them delivered to the pharmacy. Total cost $900 with GoodRx and 3 doses so takes time. Doable but expensive and takes a lot of effort to arrange (in my experience).
So happy to see this paper out after a lot of persistence from Shardul Rathod @hannahnam.bsky.social @ucirvine.bsky.social.
Over a 10 yr period, 6.6% of Flu cases, 12.2% of RSV cases, and 10.9% of PIV cases were Hosp-Acquired. Most in ICH.
onlinelibrary.wiley.com/doi/10.1111/...
I had the HUGE honor of being the 40th Forbes Fellow - when I was the previous awardees, I was truly humbled. The ID community is incredible in Melbourne. @monashuniversity.bsky.social @unimelb.bsky.social @thedohertyinst.bsky.social @trubianojason.bsky.social @bradgardiner.bsky.social
Important Ongoing Studies where we have or will have publications soon:
Pritelivir for refractory or resistant HSV (presented @idweek.bsky.social by @kottonnelson.bsky.social): www.aicuris.com/press-releas...
CD388 for prevention of influenza: www.cidara.com/news/cidara-...
Results from season 3 of the GSK RSV Vaccine (NOTE - I was the lead author so I’m biased on this one)
www.thelancet.com/journals/lan...
Two trials on tecovirimat for Mpox and the need to consider research in context of EUA medications
www.nejm.org/doi/full/10....
evidence.nejm.org/doi/full/10....
Study of baloxavir to prevent household transmission of influenza
www.nejm.org/doi/full/10....
Two studies of monoclonals for RSV prevention
www.nejm.org/doi/full/10....
www.thelancet.com/journals/lan...
Two trials on lenacapravir for prevention of HIV
www.nejm.org/doi/full/10....
www.nejm.org/doi/10.1056/...
Two trials on high dose influenza vaccine
jamanetwork.com/journals/jam...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/abs/10.1...
Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight:
See next posts
Thanks to Lara Danziger-Isakov for doing the talk.
Slides:
www.dropbox.com/scl/fi/nj1z8...
Due to the US Government Shutdown, I will not be able to atted @IDWeek.bsky.social #IDWeek2025. I had worked on my 2 invited talks and so will share them.
My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.
Included in the supplement is an important paper about application of antivirals in immunocompromised patients @mady247.bsky.social
academic.oup.com/jid/article/...
Excited to see the “Advances in Influenza Therapeutics” supplement out in @jidjournal.bsky.social - led by Fred Hayden and Rich Whitley, this supplement reviews what we know about antivirals and how they should be used for influenza.
academic.oup.com/jid/issue/23...
Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!
check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with
@michaelisonmd.bsky.social
on this! #TxID doi.org/10.1016/j.jh...
The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.
Excited to have this paper out! Demonstrates that the recipients of lung 🫁 tx for COVID-Associated Lung Injury (CALI) loose humoral protection and have unique cellular immune responses.
www.sciencedirect.com/science/arti...
AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate.
ajt-transplant-id-exchange.squarespace.com
Don't miss the new @amjtransplant.bsky.social #TxID blog led by Emily Blumberg ajt-transplant-id-exchange.squarespace.com #wtc2025 @ast-idcop.bsky.social @ast-tyfcop.bsky.social @astinfo.bsky.social
Excited to head to San Francisco for #WTC2025 @ast-idcop.bsky.social
Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs.
www.science.org/doi/10.1126/...
Likewise, screening for FQ resistance may inform what breakthrough infections will occur and optimize early management.
Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.
Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.
Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs
onlinelibrary.wiley.com/doi/10.1111/...
The future may be using the tool to look at pathogen and host response in the same assay - multiple examples shown that the combined approach provided answers that wouldn’t have been identified.
